Other Outstanding Securities/Financing Restrictions. Except as disclosed in the Reports, the Company has no outstanding restricted shares, or shares of Common Stock sold under Regulation S, Regulation D or outstanding under any other exemption from registration, which are available for sale as unrestricted ("free trading") stock.
Other Outstanding Securities/Financing Restrictions. As of the date hereof, other than warrants and options to acquire shares of Common Stock as disclosed in Schedule 4.3, there are no other warrants and options registered with the SEC, which are available for sale as unrestricted ("free trading") stock.
Other Outstanding Securities/Financing Restrictions. Except as disclosed in the Reports, and Addenda 1, there are no other outstanding securities, debt or equity presently convertible into Common Stock. Except as disclosed in the Reports, and herein, the Company has no outstanding restricted shares, or shares of Common Stock sold under Regulation S, Regulation D or outstanding under any other exemption from registration, which are available for sale as unrestricted ("free trading") stock.
Other Outstanding Securities/Financing Restrictions. Except as set forth on the CXI SEC Reports (as defined herein) or as contemplated hereby, there are no other outstanding debt or equity securities presently convertible into shares of CXI Common Stock. COES contemplates selling an aggregate of approximately 25,000 shares of COES Preferred Shares (including the shares being offered and sold hereby) contemporaneously herewith, and issuing an aggregate of approximately 462,500 additional COES Warrants contemporaneously herewith, of which 150,000 such warrants will be issued to entities which acquired COES Preferred Shares in May 1997 and the balance are anticipated to be issued contemporaneously herewith to acquirors of additional COES Preferred Shares (including the Purchaser). The Parent Company cannot, without the prior approval in writing from the Purchaser, obtain convertible debt or equity financing which is convertible into securities of the Subsidiary Company for a period of ninety (90) days following the effective date of the Registration Statement (as defined herein); however, the Parent Company will not require prior approval if (a) at least 80% of the net proceeds of the financing is part of an acquisition by the Parent Company of control of another company or entity, (b) at least 80% of the net proceeds of the financing is a refinancing of the Parent Company's debt, or (c) the financing is part of a public offering of the Parent Company's securities.
Other Outstanding Securities/Financing Restrictions. Except as set forth in the CXI SEC Reports or as contemplated hereby, there are no other outstanding
Other Outstanding Securities/Financing Restrictions. Other than warrants and options to acquire shares of Common Stock as disclosed in the SEC Documents, there are registration, which are available for sale as unrestricted ("free trading") stock.
Other Outstanding Securities/Financing Restrictions. Other than the Common Stock, Preferred Stock, and warrants and options disclosed in Section III.2 hereto, there are no other outstanding securities, debt or equity presently convertible into Common Stock.
Other Outstanding Securities/Financing Restrictions. Other than warrants and options to acquire shares of Common Stock as disclosed in the Reports, options issued to certain employees in January, 1998 pursuant to the Company's stock option plan, and an aggregate of 750,000 options recently issued to the Company's officers and directors, and except as disclosed in the reports there are no other outstanding securities, debt or equity presently convertible into Common Stock. Except as disclosed in the Reports, the Company has no outstanding restricted shares, or shares of Common Stock sold under Regulation S, Regulation D or outstanding under any other exemption from registration, which are available for sale as unrestricted ("free trading") stock.
Other Outstanding Securities/Financing Restrictions. Except as set forth on the CXI SEC Reports (as defined herein), there are no other outstanding debt or equity securities presently convertible into shares of CXI Common Stock. The Parent Company cannot, without the prior approval in writing from the Purchaser, obtain convertible debt or equity financing which is convertible into securities of the Subsidiary Company for a period of ninety (90) days following the effective date of the Registration Statement (as defined herein); however, the Parent Company will not require prior approval if (a) at least 80% of the net proceeds of the financing is part of an acquisition by the Parent Company of control of another company or entity, (b) at least 80% of the net proceeds of the financing is a refinancing of the Parent Company's debt, or (c) the financing is part of a public offering of the Parent Company's securities.
Other Outstanding Securities/Financing Restrictions. Except as set forth in the CXI SEC Reports, there are no other outstanding debt or equity securities presently convertible into shares of CXI Common Stock. Except as set forth in the CXI SEC Reports, the Subsidiary Company has no outstanding restricted shares of Common Stock, or shares of Common Stock sold under Regulation S or Regulation D under the Securities Act of 1933, as amended (the "Securities Act") or outstanding under any other exemption from registration, which are available for sale as unrestricted ("free trading") stock. The Subsidiary Company cannot, without the prior approval in writing from the Purchaser, obtain convertible debt or equity financing for a period of ninety (90) days following the effective date of the Registration Statement (as defined herein); however, the Subsidiary Company will not require prior approval if (a) at least 80% of the net proceeds of the financing is part of an acquisition by the Subsidiary Company of control of another company or entity, (b) at least 80% of the net proceeds of the financing is a refinancing of the Subsidiary Company's debt, or (c) the financing is part of a public offering of the Subsidiary Company's securities.
